Acute abdominal pain during therapy with glucantim: splenic infarct or excessive splenic enlargement?
Malta
R
R
Department of Internal Medicine University of Palermo, Italy.
Affronti
M
M
Di Rosa
S
S
Scardavi
M
M
Renda
M
M
Trifiró
G
G
Peralta
S
S
Savalli
F
F
Rini
G B
GB
D015746:Abdominal Pain / Q000139:chemically induced*; D000293:Adolescent; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D006801:Humans; D007238:Infarction / Q000139:chemically induced; D008297:Male; D008536:Meglumine / Q000009:adverse effects*; D000077485:Meglumine Antimoniate; D008875:Middle Aged; D009942:Organometallic Compounds / Q000009:adverse effects*; D013154:Spleen / Q000098:blood supply; D013163:Splenomegaly / Q000139:chemically induced; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate